Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Core and Main Inc (CNM) vs TG Therapeutics Inc (TGTX) Price & Performance

Core and Main IncTrade
TG Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Core and Main Inc vs TG Therapeutics Inc — how do they compare? Core and Main Inc trades at $46.07 (market cap $8.62B), while TG Therapeutics Inc trades at $47.68 (market cap $7.58B). The key difference: Core and Main Inc and TG Therapeutics Inc are close in size by market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Core and Main Inc nearer its low. Which is the better fit depends on your goals.

CNMTGTX
Market Cap
$8.62B$7.58B
Sector
TechnologyHealth
52-Week High
$66.98$59.06
52-Week Low
$42.37$26.94
Enterprise Value
$10.92B$7.78B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Core and Main Inc

Core & Main is a leading US distributor of water, wastewater, storm drainage, and fire protection products. It provides essential infrastructure solutions to municipalities, private water companies, and contractors.

Read more on CNM

About TG Therapeutics Inc

TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.

Read more on TGTX